COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D PXPX FLVFLV PVP-IPI BUBU BHBH BLBL CICI HC QHC Q NZNZ COCO More..
00.250.50.7511.251.51.752+Deftereos (RCT)77%0.23 [0.03-1.97]death1/554/50Improvement, RR [CI]TreatmentControlLopes (DB RCT)80%0.20 [0.01-4.03]death0/362/36Brunetti (PSM)73%0.27 [0.08-0.89]death3/3311/33Scarsi85%0.15 [0.06-0.37]death122 (n)140 (n)Pinzón35%0.65 [0.34-1.21]death14/14523/156Sandhu42%0.58 [0.40-0.85]death16/3463/78Rodriguez-Nava6%0.94 [0.61-1.47]death16/5285/261Tardif (DB RCT)44%0.56 [0.19-1.67]death5/2,2359/2,253Horby (RCT)-1%1.01 [0.93-1.10]death1,173/5,6101,190/5,730Gaitán-Dua.. (RCT)19%0.81 [0.48-1.35]death22/15328/161CT​1Tau​2 = 0.17; I​2 = 74.5%Late treatment40%0.60 [0.42-0.86]1,250/8,4751,415/8,89840% improvementAll studies40%0.60 [0.42-0.86]1,250/8,4751,415/8,89840% improvement10 colchicine COVID-19 studiesc19colchicine.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.17; I​2 = 74.5%; Z = 2.82Effect extraction pre-specifiedLower RiskIncreased Risk 00.250.50.7511.251.51.752+Deftereos (RCT)77%0.23 [0.03-1.97]1/554/50Improvement, RR [CI]TreatmentControlLopes (DB RCT)80%0.20 [0.01-4.03]0/362/36Brunetti (PSM)73%0.27 [0.08-0.89]3/3311/33Scarsi85%0.15 [0.06-0.37]122 (n)140 (n)Pinzón35%0.65 [0.34-1.21]14/14523/156Sandhu42%0.58 [0.40-0.85]16/3463/78Rodriguez-Nava6%0.94 [0.61-1.47]16/5285/261Tardif (DB RCT)44%0.56 [0.19-1.67]5/2,2359/2,253Horby (RCT)-1%1.01 [0.93-1.10]1,173/5,6101,190/5,730Gaitán-Dua.. (RCT)19%0.81 [0.48-1.35]22/15328/161CT​1Tau​2 = 0.17; I​2 = 74.5%Late treatment40%0.60 [0.42-0.86]1,250/8,4751,415/8,89840% improvementAll studies40%0.60 [0.42-0.86]1,250/8,4751,415/8,89840% improvement10 colchicine COVID-19 mortality resultsc19colchicine.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.17; I​2 = 74.5%; Z = 2.82Lower RiskIncreased Risk 00.250.50.7511.251.51.752+Lopes (DB RCT)50%0.50 [0.10-2.56]2/364/36Improvement, RR [CI]TreatmentControlGaitán-Dua.. (RCT)1%0.99 [0.56-1.74]19/11318/114CT​1Tau​2 = 0.00; I​2 = 0.0%Late treatment9%0.91 [0.53-1.59]21/14922/1509% improvementAll studies9%0.91 [0.53-1.59]21/14922/1509% improvement2 colchicine COVID-19 ICU resultsc19colchicine.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.00; I​2 = 0.0%; Z = 0.31Lower RiskIncreased Risk 00.250.50.7511.251.51.752+Tardif (DB RCT)20%0.80 [0.61-1.03]hosp.101/2,235128/2,253Improvement, RR [CI]TreatmentControlTau​2 = 0.00; I​2 = 0.0%Late treatment20%0.80 [0.61-1.03]101/2,235128/2,25320% improvementAll studies20%0.80 [0.62-1.03]101/2,235128/2,25320% improvement1 colchicine COVID-19 hospitalization resultc19colchicine.com Aug 29, 2021Tau​2 = 0.00; I​2 = 0.0%; Z = 1.72Lower RiskIncreased Risk 00.250.50.7511.251.51.752+Deftereos (RCT)77%0.23 [0.03-1.97]death1/554/50Improvement, RR [CI]TreatmentControlLopes (DB RCT)80%0.20 [0.01-4.03]death0/362/36Brunetti (PSM)73%0.27 [0.08-0.89]death3/3311/33Scarsi85%0.15 [0.06-0.37]death122 (n)140 (n)Pinzón35%0.65 [0.34-1.21]death14/14523/156Sandhu42%0.58 [0.40-0.85]death16/3463/78Rodriguez-Nava6%0.94 [0.61-1.47]death16/5285/261Tardif (DB RCT)44%0.56 [0.19-1.67]death5/2,2359/2,253Horby (RCT)-1%1.01 [0.93-1.10]death1,173/5,6101,190/5,730Gaitán-Dua.. (RCT)19%0.81 [0.48-1.35]death22/15328/161CT​1Tau​2 = 0.17; I​2 = 74.5%Late treatment40%0.60 [0.42-0.86]1,250/8,4751,415/8,89840% improvementAll studies40%0.60 [0.42-0.86]1,250/8,4751,415/8,89840% improvement10 colchicine COVID-19 serious outcomesc19colchicine.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.17; I​2 = 74.5%; Z = 2.82Effect extraction pre-specifiedLower RiskIncreased Risk 00.250.50.7511.251.51.752+Deftereos (RCT)77%0.23 [0.03-1.97]death1/554/50Improvement, RR [CI]TreatmentControlLopes (DB RCT)80%0.20 [0.01-4.03]death0/362/36Tardif (DB RCT)44%0.56 [0.19-1.67]death5/2,2359/2,253Horby (RCT)-1%1.01 [0.93-1.10]death1,173/5,6101,190/5,730Gaitán-Dua.. (RCT)19%0.81 [0.48-1.35]death22/15328/161CT​1Tau​2 = 0.02; I​2 = 15.2%Late treatment8%0.92 [0.72-1.17]1,201/8,0891,233/8,2308% improvementAll studies8%0.92 [0.72-1.17]1,201/8,0891,233/8,2308% improvement5 colchicine COVID-19 Randomized Controlled Trialsc19colchicine.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.02; I​2 = 15.2%; Z = 0.69Effect extraction pre-specifiedLower RiskIncreased Risk 00.250.50.7511.251.51.752+Deftereos (RCT)77%0.23 [0.03-1.97]1/554/50Improvement, RR [CI]TreatmentControlLopes (DB RCT)80%0.20 [0.01-4.03]0/362/36Tardif (DB RCT)44%0.56 [0.19-1.67]5/2,2359/2,253Horby (RCT)-1%1.01 [0.93-1.10]1,173/5,6101,190/5,730Gaitán-Dua.. (RCT)19%0.81 [0.48-1.35]22/15328/161CT​1Tau​2 = 0.02; I​2 = 15.2%Late treatment8%0.92 [0.72-1.17]1,201/8,0891,233/8,2308% improvementAll studies8%0.92 [0.72-1.17]1,201/8,0891,233/8,2308% improvement5 colchicine COVID-19 RCT mortality resultsc19colchicine.com Aug 29, 20211 CT: study uses combined treatmentTau​2 = 0.02; I​2 = 15.2%; Z = 0.69Lower RiskIncreased Risk 00.250.50.7511.251.51.752+Deftereos (RCT)77%0.23 [0.03-1.97]death1/554/50Improvement, RR [CI]TreatmentControlLopes (DB RCT)80%0.20 [0.01-4.03]death0/362/36Brunetti (PSM)73%0.27 [0.08-0.89]death3/3311/33Scarsi85%0.15 [0.06-0.37]death122 (n)140 (n)Sandhu42%0.58 [0.40-0.85]death16/3463/78Rodriguez-Nava6%0.94 [0.61-1.47]death16/5285/261Tardif (DB RCT)44%0.56 [0.19-1.67]death5/2,2359/2,253Tau​2 = 0.26; I​2 = 63.0%Late treatment56%0.44 [0.26-0.76]41/2,567174/2,85156% improvementAll studies56%0.44 [0.26-0.76]41/2,567174/2,85156% improvement7 colchicine COVID-19 peer reviewed trialsc19colchicine.com Aug 29, 2021Tau​2 = 0.26; I​2 = 63.0%; Z = 2.97Effect extraction pre-specifiedLower RiskIncreased Risk 00.250.50.7511.251.51.752+Deftereos (RCT)77%0.23 [0.03-1.97]death1/554/50Improvement, RR [CI]TreatmentControlDeftereos (RCT)82%0.18 [0.02-1.50]ventilation1/555/50Deftereos (RCT)87%0.13 [0.01-0.97]progression1/557/50Lopes (DB RCT)80%0.20 [0.01-4.03]death0/362/36Lopes (DB RCT)50%0.50 [0.10-2.56]ICU2/364/36Brunetti (PSM)73%0.27 [0.08-0.89]death3/3311/33Brunetti (PSM)73%0.27 [0.08-0.89]no disch.3/3311/33Scarsi85%0.15 [0.06-0.37]death122 (n)140 (n)Pinzón35%0.65 [0.34-1.21]death14/14523/156Sandhu42%0.58 [0.40-0.85]death16/3463/78Sandhu53%0.47 [0.33-0.67]ventilation16/3468/68Sandhu42%0.58 [0.40-0.85]no disch.16/3463/78Rodriguez-Nava6%0.94 [0.61-1.47]death16/5285/261Tardif (DB RCT)44%0.56 [0.19-1.67]death5/2,2359/2,253Tardif (DB RCT)47%0.53 [0.25-1.09]ventilation11/2,23521/2,253Tardif (DB RCT)20%0.80 [0.61-1.03]hosp.101/2,235128/2,253Horby (RCT)-1%1.01 [0.93-1.10]death1,173/5,6101,190/5,730Gaitán-Dua.. (RCT)19%0.81 [0.48-1.35]death22/15328/161CT​1Gaitán-Dua.. (RCT)15%0.85 [0.68-1.06]ventilation27/13627/140CT​1Gaitán-Dua.. (RCT)1%0.99 [0.56-1.74]ICU19/11318/114CT​1colchicine COVID-19 outcomesc19colchicine.com Aug 29, 2021Lower RiskIncreased Risk
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit    
Aspirin
Bamlanivimab
Bromhexine
Budesonide
Casirivimab/i..
Colchicine
Curcumin
Favipiravir
Fluvoxamine
Hydroxychloro..
Iota-carragee..
Ivermectin
Melatonin
Molnupiravir
Nigella Sativa
Nitazoxanide
Povidone-Iod..
Probiotics
Proxalutamide
Quercetin
Remdesivir
Sotrovimab
Vitamin C
Vitamin D
Zinc

Other
Feedback
Home